Efficacy of darbepoetin alfa in chemotherapy-induced anemia in gastrointestinal cancers.

被引：0
|
作者：
Blayney, D
Vadhan-Raj, S
Tomita, D
Rossi, G
Mirtsching, B
机构：
[1] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Ctr Oncol Res & Treatment, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：781S / 781S
页数：1
相关论文
共 50 条
  • [21] Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
    Boccia, Ralph
    Malik, Imtiaz A.
    Raja, Vinay
    Kahanic, Stephen
    Liu, Randall
    Lillie, Tom
    Tomita, Dianne
    Clowney, Billy
    Silberstein, Peter
    ONCOLOGIST, 2006, 11 (04): : 409 - 417
  • [22] A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia
    Justice, G
    Kessler, JF
    Jadeja, J
    Campos, L
    Weick, J
    Chen, CF
    Heatherington, AC
    Amado, RG
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1192 - 1198
  • [23] Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.
    Navari, Rudolph M.
    Jordan, Karin
    Rapoport, Bernardo Leon
    Schnadig, Ian D.
    Chasen, Martin
    Arora, Sujata
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [24] A PROSPECTIVE DATA AUDIT OF THE MANAGEMENT OF CHEMOTHERAPY-INDUCED ANEMIA WITH DARBEPOETIN ALFA - THE APRIORI STUDY
    Boguradzki, P.
    Boer, K.
    Cipkova, A.
    Wojciechowska-Lampka, E.
    Schuetzova, M.
    Ocvirk, J.
    Toth, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 504 - 504
  • [25] Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia
    Bustos, Aurelia
    Alvarez, Ruth
    Miguel Aramburo, Pedro
    Carabantes, Francisco
    Diaz, Nieves
    Florian, Jesus
    Lazaro, Martin
    Maria Martin de Segovia, Jose
    Antonio Gasquet, Jose
    Alegre, Adrian
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 57 - 67
  • [26] The use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
    Vansteenkiste, J
    Wauters, I
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 429 - 440
  • [27] The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia
    Ben-Hamadi, R
    Duh, MS
    Aggarwal, J
    Henckler, A
    McKenzie, RS
    Piech, CT
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1677 - 1682
  • [28] Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study
    Cho, Minkwan
    Park, Eunkyung
    Lee, Yong-Pyo
    Kim, Hongsik
    Park, Hee Sue
    Kim, Hee Kyung
    Yang, Yaewon
    Kwon, Jihyun
    Lee, Ki Hyeong
    Han, Hye Sook
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [29] Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia.
    Ben-Hamadi, R
    Duh, MS
    Henchler, A
    McKenzie, S
    Fastenau, J
    Piech, CT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 551S - 551S
  • [30] Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL
    Pirker, Robert
    Hedenus, Michael
    Vansteenkiste, Johan
    Hernandez, Enrique
    Belton, Laura
    Terwey, Jan-Henrik
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 122 - 135
12345